Oculis
ExitedOculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.
Oculis has raised €237M across 5 funding rounds from 14 investors, most recently a Debt round in Aug 2025. Based in Lausanne, Switzerland; founded 2003; active in Healthtech. The company has exited (2022). Data as of 28 Oct 2026.
Total raised
€237M
€236,869,918
Funding rounds
5
Investors
14
distinct backers
Active since
2019-01
latest 2025-08
Funding by year
EUR raised per yearOculis — funding by year — interactive chart.
Data table
| Oculis — funding by year | |
|---|---|
| 2018 | €14M |
| 2021 | €47M |
| 2023 | €14M |
| 2024 | €55M |
| 2025 | €106M |
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-13 | Debt | €106M | BlackRock | View deal → |
| 2024-04-12 | Other | €55M | Existing investors | View deal → |
| 2023-02-06 | Other | €14M | — | View deal → |
| 2021-05-05 | Series C | €47M | Bay City Capital,Brunnur Ventures,BVCF Management,Earlybird Venture Capital,Hyfinity Investments,Nan Fung Life Sciences+6 more | View deal → |
| 2019-01-01 | Series B | €14M | Tekla Capital Management | View deal → |
Exit
Type
ipo
Date
Oct 2022
Value
€82M
Acquiror
—
Investors
14Related news
- Oculis raises an additional $15M in funding before going publicnorthstack.is · 2023-02
- Oculis raises $80M and goes public through a SPAC mergernorthstack.is · 2022-10
- siliconcanals.com
- eu-startups.com
- finsmes.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData